| 211.7 | BENIGN NEOPLASM OF ISLETS OF LANGERHANS |
| 249.00 | SECONDARY DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION
NOT STATED AS UNCONTROLLED OR UNSPECIFIED |
| 249.01 | SECONDARY DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION
UNCONTROLLED |
| 249.10 | SECONDARY DIABETES MELLITUS WITH KETOACIDOSIS NOT STATED AS
UNCONTROLLED OR UNSPECIFIED |
| 249.11 | SECONDARY DIABETES MELLITUS WITH KETOACIDOSIS UNCONTROLLED |
| 249.20 | SECONDARY DIABETES MELLITUS WITH HYPEROSMOLARITY NOT STATED
AS UNCONTROLLED OR UNSPECIFIED |
| 249.21 | SECONDARY DIABETES MELLITUS WITH HYPEROSMOLARITY
UNCONTROLLED |
| 249.30 | SECONDARY DIABETES MELLITUS WITH OTHER COMA NOT STATED AS
UNCONTROLLED OR UNSPECIFIED |
| 249.31 | SECONDARY DIABETES MELLITUS WITH OTHER COMA UNCONTROLLED |
| 249.40 | SECONDARY DIABETES MELLITUS WITH RENAL MANIFESTATION NOT
STATED AS UNCONTROLLED OR UNSPECIFIED |
| 249.41 | SECONDARY DIABETES MELLITUS WITH RENAL MANIFESTATION
UNCONTROLLED |
| 249.50 | SECONDARY DIABETES MELLITUS WITH OPHTHALMIC MANIFESTATION
NOT STATED AS UNCONTROLLED OR UNSPECIFIED |
| 249.51 | SECONDARY DIABETES MELLITUS WITH OPHTHALMIC MANIFESTATION
UNCONTROLLED |
| 249.60 | SECONDARY DIABETES MELLITUS WITH NEUROLOGICAL MANIFESTATION
NOT STATED AS UNCONTROLLED OR UNSPECIFIED |
| 249.61 | SECONDARY DIABETES MELLITUS WITH NEUROLOGICAL MANIFESTATION
UNCONTROLLED |
| 249.70 | SECONDARY DIABETES MELLITUS WITH PERIPHERAL CIRCULATORY
MANIFESTATION NOT STATED AS UNCONTROLLED OR UNSPECIFIED |
| 249.71 | SECONDARY DIABETES MELLITUS WITH PERIPHERAL CIRCULATORY
MANIFESTATION UNCONTROLLED |
| 249.80 | SECONDARY DIABETES MELLITUS WITH OTHER SPECIFIED
MANIFESTATION NOT STATED AS UNCONTROLLED OR UNSPECIFIED |
| 249.81 | SECONDARY DIABETES MELLITUS WITH OTHER SPECIFIED
MANIFESTATION UNCONTROLLED |
| 249.90 | SECONDARY DIABETES MELLITUS WITH UNSPECIFIED COMPLICATION
NOT STATED AS UNCONTROLLED OR UNSPECIFIED |
| 249.91 | SECONDARY DIABETES MELLITUS WITH UNSPECIFIED COMPLICATION
UNCONTROLLED |
| 250.00 | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION TYPE II
OR UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED |
| 250.01 | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION TYPE I
[JUVENILE TYPE] NOT STATED AS UNCONTROLLED |
| 250.02 | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION TYPE II
OR UNSPECIFIED TYPE UNCONTROLLED |
| 250.03 | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION TYPE I
[JUVENILE TYPE] UNCONTROLLED |
| 250.10 | DIABETES WITH KETOACIDOSIS TYPE II OR UNSPECIFIED TYPE NOT
STATED AS UNCONTROLLED |
| 250.11 | DIABETES WITH KETOACIDOSIS TYPE I [JUVENILE TYPE] NOT
STATED AS UNCONTROLLED |
| 250.12 | DIABETES WITH KETOACIDOSIS TYPE II OR UNSPECIFIED TYPE
UNCONTROLLED |
| 250.13 | DIABETES WITH KETOACIDOSIS TYPE I [JUVENILE TYPE]
UNCONTROLLED |
| 250.20 | DIABETES WITH HYPEROSMOLARITY TYPE II OR UNSPECIFIED TYPE
NOT STATED AS UNCONTROLLED |
| 250.21 | DIABETES WITH HYPEROSMOLARITY TYPE I [JUVENILE TYPE] NOT
STATED AS UNCONTROLLED |
| 250.22 | DIABETES WITH HYPEROSMOLARITY TYPE II OR UNSPECIFIED TYPE
UNCONTROLLED |
| 250.23 | DIABETES WITH HYPEROSMOLARITY TYPE I [JUVENILE TYPE]
UNCONTROLLED |
| 250.30 | DIABETES WITH OTHER COMA TYPE II OR UNSPECIFIED TYPE NOT
STATED AS UNCONTROLLED |
| 250.31 | DIABETES WITH OTHER COMA TYPE I [JUVENILE TYPE] NOT STATED
AS UNCONTROLLED |
| 250.32 | DIABETES WITH OTHER COMA TYPE II OR UNSPECIFIED TYPE
UNCONTROLLED |
| 250.33 | DIABETES WITH OTHER COMA TYPE I [JUVENILE TYPE]
UNCONTROLLED |
| 250.40 | DIABETES WITH RENAL MANIFESTATIONS TYPE II OR UNSPECIFIED
TYPE NOT STATED AS UNCONTROLLED |
| 250.41 | DIABETES WITH RENAL MANIFESTATIONS TYPE I [JUVENILE TYPE]
NOT STATED AS UNCONTROLLED |
| 250.42 | DIABETES WITH RENAL MANIFESTATIONS TYPE II OR UNSPECIFIED
TYPE UNCONTROLLED |
| 250.43 | DIABETES WITH RENAL MANIFESTATIONS TYPE I [JUVENILE TYPE]
UNCONTROLLED |
| 250.50 | DIABETES WITH OPHTHALMIC MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED |
| 250.51 | DIABETES WITH OPHTHALMIC MANIFESTATIONS TYPE I [JUVENILE
TYPE] NOT STATED AS UNCONTROLLED |
| 250.52 | DIABETES WITH OPHTHALMIC MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE UNCONTROLLED |
| 250.53 | DIABETES WITH OPHTHALMIC MANIFESTATIONS TYPE I [JUVENILE
TYPE] UNCONTROLLED |
| 250.60 | DIABETES WITH NEUROLOGICAL MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED |
| 250.61 | DIABETES WITH NEUROLOGICAL MANIFESTATIONS TYPE I [JUVENILE
TYPE] NOT STATED AS UNCONTROLLED |
| 250.62 | DIABETES WITH NEUROLOGICAL MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE UNCONTROLLED |
| 250.63 | DIABETES WITH NEUROLOGICAL MANIFESTATIONS TYPE I [JUVENILE
TYPE] UNCONTROLLED |
| 250.70 | DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS TYPE II OR
UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED |
| 250.71 | DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS TYPE I
[JUVENILE TYPE] NOT STATED AS UNCONTROLLED |
| 250.72 | DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS TYPE II OR
UNSPECIFIED TYPE UNCONTROLLED |
| 250.73 | DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS TYPE I
[JUVENILE TYPE] UNCONTROLLED |
| 250.80 | DIABETES WITH OTHER SPECIFIED MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED |
| 250.81 | DIABETES WITH OTHER SPECIFIED MANIFESTATIONS TYPE I
[JUVENILE TYPE] NOT STATED AS UNCONTROLLED |
| 250.82 | DIABETES WITH OTHER SPECIFIED MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE UNCONTROLLED |
| 250.83 | DIABETES WITH OTHER SPECIFIED MANIFESTATIONS TYPE I
[JUVENILE TYPE] UNCONTROLLED |
| 250.90 | DIABETES WITH UNSPECIFIED COMPLICATION TYPE II OR
UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED |
| 250.91 | DIABETES WITH UNSPECIFIED COMPLICATION TYPE I [JUVENILE
TYPE] NOT STATED AS UNCONTROLLED |
| 250.92 | DIABETES WITH UNSPECIFIED COMPLICATION TYPE II OR
UNSPECIFIED TYPE UNCONTROLLED |
| 250.93 | DIABETES WITH UNSPECIFIED COMPLICATION TYPE I [JUVENILE
TYPE] UNCONTROLLED |
| 251.0 | HYPOGLYCEMIC COMA |
| 251.1 | OTHER SPECIFIED HYPOGLYCEMIA |
| 251.2 | HYPOGLYCEMIA UNSPECIFIED |
| 251.3 | POSTSURGICAL HYPOINSULINEMIA |
| 251.4 | ABNORMALITY OF SECRETION OF GLUCAGON |
| 251.8 | OTHER SPECIFIED DISORDERS OF PANCREATIC INTERNAL SECRETION |
| 251.9 | UNSPECIFIED DISORDER OF PANCREATIC INTERNAL SECRETION |
| 258.01 | MULTIPLE ENDOCRINE NEOPLASIA [MEN] TYPE I |
| 258.02 | MULTIPLE ENDOCRINE NEOPLASIA [MEN] TYPE IIA |
| 258.03 | MULTIPLE ENDOCRINE NEOPLASIA [MEN] TYPE IIB |
| 258.9 | POLYGLANDULAR DYSFUNCTION UNSPECIFIED |
| 271.4 | RENAL GLYCOSURIA |
| 275.0 | DISORDERS OF IRON METABOLISM |
| 577.1 | CHRONIC PANCREATITIS |
| 579.3 | OTHER AND UNSPECIFIED POSTSURGICAL NONABSORPTION |
| 648.00 | DIABETES MELLITUS OF MOTHER COMPLICATING PREGNANCY
CHILDBIRTH OR THE PUERPERIUM UNSPECIFIED AS TO EPISODE OF
CARE |
| 648.03 | ANTEPARTUM DIABETES MELLITUS |
| 648.04 | POSTPARTUM DIABETES MELLITUS |
| 648.80 | ABNORMAL GLUCOSE TOLERANCE OF MOTHER COMPLICATING PREGNANCY
CHILDBIRTH OR THE PUERPERIUM UNSPECIFIED AS TO EPISODE OF
CARE |
| 648.83 | ABNORMAL GLUCOSE TOLERANCE OF MOTHER ANTEPARTUM |
| 648.84 | ABNORMAL GLUCOSE TOLERANCE OF MOTHER POSTPARTUM |
| 790.21 | IMPAIRED FASTING GLUCOSE |
| 790.22 | IMPAIRED GLUCOSE TOLERANCE TEST (ORAL) |
| 790.29 | OTHER ABNORMAL GLUCOSE |
| 790.6 | OTHER ABNORMAL BLOOD CHEMISTRY |
| 962.3 | POISONING BY INSULINS AND ANTIDIABETIC AGENTS |
| V12.2 | PERSONAL HISTORY OF ENDOCRINE METABOLIC AND IMMUNITY
DISORDERS |
| V58.67 | LONG-TERM (CURRENT) USE OF INSULIN |
| V58.69 | LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS |
